Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Endocarditis I: Introduction01:25

Endocarditis I: Introduction

752
Introduction:Endocarditis is the infection of the endocardium, the inner lining of the heart and its valves. When the heart muscle is involved, the condition is termed myocarditis, while an infection of the outer lining is called pericarditis. Infective endocarditis (IE) primarily affects the endocardium, where pathogens adhere to the valves or lining, forming vegetation that can lead to severe complications. Infective endocarditis occurs when microorganisms, usually bacteria from other body...
752
Endocarditis IV: Nursing Management01:29

Endocarditis IV: Nursing Management

567
Infective endocarditis (IE) is a chronic infection of the heart's endocardium, primarily affecting the heart valves. A detailed nursing assessment for a patient with IE involves collecting subjective and objective data to ensure an accurate diagnosis and timely intervention.Subjective DataThe nurse gathers information about the patient's symptoms and complaints during the subjective assessment. Patients with infective endocarditis often report non-specific symptoms that can mimic other...
567
Endocarditis II: Clinical Features of Infective Endocarditis01:25

Endocarditis II: Clinical Features of Infective Endocarditis

775
Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
775
Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

330
Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
330
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

319
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
319
Hepatitis01:25

Hepatitis

34
Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver.
34

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Test-retest reliability of TMS motor evoked responses and silent periods during explosive voluntary isometric contractions.

European journal of applied physiology·2025
Same author

MPUS is a big step forward for small organs.

Ultraschall in der Medizin (Stuttgart, Germany : 1980)·2025
Same author

A comprehensive RCT in screening, surveillance, and diagnostic AI-assisted colonoscopies (ACCENDO-Colo study).

Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·2025
Same author

Positronium Laser Cooling via the 1^{3}S-2^{3}P Transition with a Broadband Laser Pulse.

Physical review letters·2024
Same author

Complications of unintentional dural puncture during labour epidural analgesia: a 10-year retrospective observational study.

Journal of anesthesia, analgesia and critical care·2023
Same author

Thyroid function, sensitivity to thyroid hormones, and metabolic syndrome in euthyroid children and adolescents with Down syndrome.

Journal of endocrinological investigation·2023

Related Experiment Video

Updated: Mar 28, 2026

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks
10:28

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks

Published on: June 26, 2020

10.4K

Infective endocarditis in patients with hepatic diseases.

E Seminari1, A De Silvestri2, V Ravasio3

  • 1Clinica di Malattie Infettive, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy. e.seminari@smatteo.pv.it.

European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology
|December 23, 2015
PubMed
Summary

Infective endocarditis (IE) patients with chronic hepatic disease (CHD) experience more complications but similar mortality rates compared to those without CHD. Chronic hepatic disease (CHD) is a significant factor worsening prognosis in infective endocarditis (IE) patients.

More Related Videos

"Liver-on-a-Chip" Cultures of Primary Hepatocytes and Kupffer Cells for Hepatitis B Virus Infection
10:25

"Liver-on-a-Chip" Cultures of Primary Hepatocytes and Kupffer Cells for Hepatitis B Virus Infection

Published on: February 19, 2019

12.3K
In vivo Liver Endocytosis Followed by Purification of Liver Cells by Liver Perfusion
12:35

In vivo Liver Endocytosis Followed by Purification of Liver Cells by Liver Perfusion

Published on: November 10, 2011

19.8K

Related Experiment Videos

Last Updated: Mar 28, 2026

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks
10:28

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks

Published on: June 26, 2020

10.4K
"Liver-on-a-Chip" Cultures of Primary Hepatocytes and Kupffer Cells for Hepatitis B Virus Infection
10:25

"Liver-on-a-Chip" Cultures of Primary Hepatocytes and Kupffer Cells for Hepatitis B Virus Infection

Published on: February 19, 2019

12.3K
In vivo Liver Endocytosis Followed by Purification of Liver Cells by Liver Perfusion
12:35

In vivo Liver Endocytosis Followed by Purification of Liver Cells by Liver Perfusion

Published on: November 10, 2011

19.8K

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Hepatology

Background:

  • Limited data exist on infective endocarditis (IE) in patients with chronic hepatic disease (CHD).
  • Understanding the epidemiology and outcomes of IE in this population is crucial for improved patient management.

Purpose of the Study:

  • To evaluate the epidemiology and outcomes of IE in patients with chronic hepatic disease (CHD+) compared to those without (CHD-).

Main Methods:

  • Retrospective analysis of the Studio Endocarditi Italiano (SEI) database.
  • Inclusion of 1722 IE episodes, with 300 in CHD+ patients.
  • Diagnosis of IE according to modified Duke criteria.

Main Results:

  • Patients with CHD experienced higher complication rates (77% vs. 65.3%), including embolization and congestive heart failure.
  • Surgical intervention rates were similar (38.9% vs. 43.7%), and mortality rates were comparable (15% vs. 12.5%).
  • Staphylococcus aureus was the most common pathogen in CHD+ patients.

Conclusions:

  • Chronic hepatic disease (CHD) is associated with a worse prognosis in infective endocarditis (IE) patients, particularly those requiring cardiac surgery.
  • While mortality is similar, increased complications highlight the vulnerability of CHD patients with IE.
  • Intravenous drug use (IVDU) emerged as a protective factor against mortality in IE patients.